INTRODUCTION
During the last decade, substantial progress has been made in determining the genetic basis of several inherited skin diseases (Lane and McLean, 2004) . Pachyonychia congenita (PC) is a rare autosomal dominant keratin disorder characterized by thickened and dystrophic nails as well as painful palmoplantar keratoderma and blisters on or near the pressure points of the feet (Leachman et al., 2005; Smith et al., 2006) . PC is caused by dominant-acting mutations (mainly point mutations and small in-frame insertion/deletion mutations) in any one of the genes encoding the differentiation-specific and stress-inducible keratins, K6a, K6b, K16, or K17 (Bowden et al., 1995; McLean et al., 1995; Smith et al., 1998) . These mutations are usually found in hot spots located near the start and end of the a-helical rod domain, regions of the keratin molecule that are critically important for polymerization (Smith et al., 2005) . The mutant keratins act in a dominant-negative manner, resulting in defective intermediate filament formation and, ultimately, appear to be responsible for all of the epithelial fragility symptoms associated with PC. Detailed analyses of the keratin mutations found in PC are presented in an accompanying article (Wilson et al., 2011) .
Although mouse models involving the PC-related keratin genes have been described, the various gene-targeting strategies applied to alter the function of relevant keratins in transgenic animals elicit only a subset of minor PC-specific epithelial lesions (Chen and Roop, 2005; Wong et al., 2005; Chen et al., 2008) . Importantly, the existing genetically modified mouse models of PC differ from the human condition in that the former are based on knockout of keratin genes (i.e., these are recessive, loss-of-function alleles), whereas the human PC mutations are dominant negative (Smith et al., 2005; Wilson et al., 2011) . However, although a transgenic mouse expressing a mutant krt75 (K6hf) (Chen et al., 2008) recapitulates many of the hair and nail defects of PC, an equivalent mutation has not been found in any of the PC patients. In addition, differences in cutaneous anatomy between mice and humans are problematic in achieving trustworthy models to study actual genotype-phenotype associations or to assess therapeutic strategies. Finally, a current approach to therapy in the keratin disorders is that of allele-specific gene silencing using small interfering RNA Leachman et al., 2008 Leachman et al., , 2010 . Owing to differences in DNA sequence between human and mouse, a humanized model system is required to test this type of highly sequence-dependent therapy.
The use of optimized tissue engineering strategies has been successful in modeling acquired or inherited human skin disorders (Escamez et al., 2004; Gache et al., 2004; Spirito et al., 2006) . A system based on the deconstruction--reconstruction of the disease through skin biopsy, keratinocyte, and fibroblast culture (deconstruction), followed by bioengineered skin preparation and grafting on immunodeficient mice (reconstruction) can be applied to generate a large number of mice engrafted with homogeneous normal or diseased human skin (Garcia et al., 2007) . In fact, we have developed a reliable preclinical humanized model of the genodermatosis dystrophic epidermolysis bullosa, which is amenable to gene correction in a clinically relevant system (Gache et al., 2004) .
In this study we report the establishment of a tissue engineering-based humanized model of PC. Starting from a skin biopsy of an uninvolved area of two PC patients (both carrying the K6a mutation p.Asn171Lys), we demonstrate epidermal phenotypic changes following induction of a hyperproliferative response in the engrafted tissue, consistent with PC features. Moreover, the use of keratinocytes from affected skin from a third patient carrying a different amino acid substitution in the same codon of the K6a gene resulted in the development of a constitutively expressed, bona fide PC phenotype. The humanized PC models described are amenable to genetic intervention as recently shown in PC patients (Leachman et al., 2010) .
RESULTS

Development of a hyperproliferation-dependent PC model
Skin punch biopsies obtained from nonlesional buttock skin areas of two PC patients harboring the K6a mutation p.Asn171Lys were used to isolate keratinocytes and fibroblasts. PC patient-derived cells grew at similar rates and exhibited similar morphological characteristics as agematched normal skin cells (data not shown). Bioengineered PC skin equivalents were grafted onto immunodeficient nu/ nu mice. After 8 to 10 weeks of grafting (the period of time needed to obtain mature regenerated human skin; Del Rio et al., 2002; Llames et al., 2004) , the recipient mice exhibited patchy pigmented human skin, which is likely because of melanocyte carryover in the keratinocyte culture (Figure 1) .
Macroscopically, the engrafted PC human skin was similar to the control human skin (Figure 1) . At the histological level, some slight differences were observed in the PC-derived skin compared with the control, particularly with regard to increased compact hyperkeratosis of the stratum corneum, which was more prominent in the PC-regenerated skin ( Figure 1 ). As in native normal human skin and uninvolved PC skin biopsies from nonpalmoplantar sites, K16 was not expressed in normal or PC-regenerated skin (Figure 1 ). Consistent with a mature and well-differentiated epidermis, K10, loricrin, and involucrin exhibited typical expression patterns (Figure 1 ), both in normal and PC-regenerated skin. The human origin of the engrafted tissue was confirmed using a monoclonal antibody specific for human involucrin that does not recognize mouse tissue (Figure 1, panel b.7) .
With the aim of identifying conditions that might better recapitulate the hyperkeratotic PC phenotype, both normal and PC skin-engrafted mice were subjected to an abrasive ''wound-like'' treatment (i.e., tape stripping), which is known to generate a hyperproliferative response with a concomitant expression of keratins K6/K16 (Ramirez et al., 1995) . As expected, analysis of both normal and PC grafts following tape stripping revealed skin thickening that, at the histological level, was observed to consist of acanthosis and K6/K16 induction ( Figure 2) . A time course and quantitative analysis of hyperproliferation-associated changes occurring after tape stripping showed that at 72, 168, and 360 hours after stripping, the response of engrafted PC skin in terms of epidermal thickening, rete ridge abnormalities, and K16 expression was more pronounced and sustained than that observed in normal, regenerated human skin at all time points (Figure 2 ). An analysis of epidermal differentiation markers 168 hours after tape stripping, the time point where epidermal thickening reaches a maximum in PC grafts, showed remarkable differences with respect to controls ( Figure 2 ). For example, immunostaining for the differentiation marker, K10, which is uniformly expressed in the suprabasal layers of the epidermis (Figure 2b ), showed a reduced and patchy expression in PC-regenerated skin ( Figure 2b ). Concomitantly, suprabasal expression of keratin K16 appeared to occur also in patches in the PC skin-derived, but not in normal skin-derived tape-stripped skin, suggesting a contribution of the aberrant K6/K16 expression to the pathogenesis of PC (Figure 2b ). Remarkably, loricrin, a major terminal differentiation marker that is normally located in the granular layer (Figure 2b ), displayed an altered pattern of staining, being negative in the hyperplastic areas in PC skin ( Figure 2b ). These results are consistent with the maintenance of an active hyperproliferative-like status, as well as persistent (and likely aberrant) K6/K16 protein expression in the PC graft ( Figure 2) .
Furthermore, although the kinetics of the hyperproliferative response (as determined by Ki67 expression) were similar in normal and PC grafts, the number of labeled nuclei in PC www.jidonline.org 1055 M García et al.
skin grafts (at peak value) was significantly higher (61 vs. 30 at 72 hours, Po0.05; Figure 3a and b). Moreover, epidermal acanthosis, the phenotypic consequence of hyperproliferation, was consistently exacerbated in PC skin grafts relative to normal tape-stripped controls at all time points (Figure 3a and c), in spite of an attenuation of the hyperproliferative response observed in both PC and control grafts. Expression of wild-type and mutant (p.Asn171Lys) K6a mRNA levels were assayed in untreated and tape-stripped (24-hour time point) human PC grafts. The results shown in Figure 3d demonstrate that both wild-type and mutant K6a mRNA levels are identically induced following tape stripping (18-fold increase). A similar induction of K16 was observed (21-fold increase), consistent with K16 being a polymerization partner of K6a. This result indicates that the phenotypic changes observed at the protein level (i.e., aberrant patchy distribution) are likely because of the induction of the mutant K6a.
Development of a spontaneous model faithfully recapitulating PC
The results obtained with cells derived from a nonlesional biopsy site where K6a is not constitutively expressed permitted us to establish a clear correlation between the induction of aberrant K6a protein and development of PC manifestations. However, the acute hyperproliferative stimulus was not sufficient to fully recapitulate the PC phenotype.
To that end, we assessed whether skin regenerated with keratinocytes (and fibroblasts) from a plantar lesional area, constitutively expressing K6/K16, were able to recapitulate the main features of the disease. At 9 weeks after grafting of plantar callus-derived PC bioengineered skin, we observed macroscopic signs of a whitish hyperkeratosis in the human skin grafts (Figure 4 ). Histopathological analysis of regenerated PC skin revealed the presence of a very prominent stratum corneum (Figure 4b ) as well as constitutive expression of K6 in the absence of tape stripping or other physical insult (Figure 4c) . A distinctive feature of differentiated plantar callus-derived skin, also found in PC-regenerated skin, was the presence of K9 (Figure 4c , inset). Expression of K9 was not detected in PC grafts derived from buttock cells (data not shown). In contrast to PC grafts derived from nonlesional skin, where vigorous tape stripping induced only epidermal acanthosis (Figures 2 and 3c) , application of very mild friction to plantar-derived PC skin developed one of the main features of the disease, namely, extensive epidermal blisters. Blisters occur in the lower suprabasal layers as demonstrated by hematoxylin and eosin staining and immunomapping with keratin K5 that predominantly labels basal keratinocytes in the base of the split (Figure 5c ). In summary, we have developed two complementary skinhumanized models, one that enables characterization of the molecular events leading to PC and a second one that more faithfully recapitulates major histopathological features of the disease. Both models are suitable for testing of pharmacological and genetic therapeutic strategies.
DISCUSSION
Several clinically relevant features of PC and other genodermatoses can be studied in patient skin biopsies or histological specimens. However, because experimentation with human volunteers is limited by ethical and practical considerations, as well as the limited number of PC patients, testing therapeutic approaches requires living preclinical models, which faithfully recapitulate the in vivo hallmarks of the disease in situ (Leachman et al., 2010) . Several mouse models have been developed by gene targeting of the PC-related keratin genes (Chen and Roop, 2005; Wong et al., 2005) . Although these mice represent excellent tools for pathogenic and functional studies, they were not designed to model PC and are unsuitable as preclinical models for testing therapies for a number of reasons. First, all PC-causing mutations are dominant negative (Wilson et al., this issue) . With an exception (Chen et al., 2008) , existing mouse models involving K6, K16, and K17 are knockout mice (McGowan et al., 2002; Chen and Roop, 2005; Wong et al., 2005) , and therefore represent recessive-acting, null alleles that are mechanistically unrelated to the human condition. Second, there are several fundamental structural differences between mouse and human skin that represent a formidable barrier for assessment of surrogate markers of efficacy if a drug-or genebased therapy is to be tested. Humanized skin models obtained through grafting human cells onto immunodeficient mice thus offers a practical solution to development of a highly realistic preclinical model of PC. In this study, we established two different humanized models of PC based on the application of an optimized cutaneous tissue engineering approach previously used to model other genodermatoses such as dystrophic epidermolysis bullosa and junctional epidermolysis bullosa (Gache et al., 2004; Spirito et al., 2006; Garcia et al., 2007) . In the latter models, blisters (the main features of the disease) were apparent immediately after skin regeneration without any external stimulus, because of the absence of functional dermal-epidermal anchoring structures resulting from the disease-causing mutations. In contrast, in our hyperproliferation-dependent PC model, the pathogenic mutant gene, the p.Asn171Lys allele of K6a, must be induced by a hyperplastic stimulus before symptoms are apparent because K6 is not expressed constitutively in the buttock skin. Therefore, following wounding by tape stripping, this model exclusively recapitulates features of the disease in similar fashion to skin areas undergoing mild abrasion or other external stress (Leachman et al., 2005) .
Although a hyperproliferation response is also observed in normal regenerated human skin, the response in PCregenerated skin was characterized by stronger, more sustained hyperplasia, as determined by epidermal thickening, Ki67 expression, and aberrant K6/K16 protein expression. It is thus conceivable that in our hyperproliferation-dependent PC model, a more persistent stimulus (e.g., repeated abrasion, ultraviolet irradiation, and so on), would be capable of worsening the condition.
The use of keratinocytes and fibroblasts derived from plantar callus, as applied in our second PC model, resulted in the retention of the phenotypic features of the donor anatomical site in the engrafted skin. These included constitutive expression of plantar keratin markers K6 and K9 (Moll et al., 1987) . Retention of donor site-specific phenotype after cultured epithelial grafting was observed previously (Stoner and Wood, 1999; Mavilio et al., 2006) . Thus, the sustained expression of mutant keratin K6 is assumed to be responsible for the recapitulation of pathognomonic signs of the disease including friction blisters. Although the source of keratinocytes and fibroblasts appears the most likely explanation for the establishment of a full PC skin phenotype, we cannot rule out some genotype-phenotype effects. Specifically, although the plantar callus-and buttock-derived cells come from different patients who carry different KRT6A mutations (p.Asn171Asp and p.Asn171Lys, respectively), the phenotype of patients with these mutations is very similar (data not shown).
Our humanized PC models, which accurately recapitulate human PC features, should be a valuable tool for developing robust therapeutic approaches for this genetic disorder as better treatments evolve. In this regard, current treatment strategies for PC are based primarily upon reduction of symptoms through a combination of mechanical debridement of nails and callus and/or through the use of nonspecific keratolytic agents that decrease the keratin burden (Leachman et al., 2005; Smith et al., 2006) . These treatments do not, however, address the underlying cause of the disorder. Oral retinoids can also be prescribed to reduce the keratoderma, but the side-effect profile is frequently unacceptable to patients, particularly for long-term use. Clearly, the treatment options for PC are inadequate and, to our knowledge previously unreported, therapeutic options are being developed including targeted molecular therapies (Leachman et al., 2010) , which will benefit from the availability of a humanized mouse model for assessment of both efficacy and cutaneous delivery optimization.
MATERIALS AND METHODS
Primary cultures of human keratinocytes and fibroblasts
Human keratinocytes and dermal fibroblasts were obtained by enzymatic digestion (Llames et al., 2004 ) from skin samples (5-mm punch biopsies) taken from the buttocks of two PC donor patients (IPCC nos. 9 and 10) carrying the p.Asn171Lys mutation and from the plantar callus of a Spanish patient (IPCC no. 245) harboring the p.Asn171Asp mutation (see www.pachyonychia.org). Participants gave their written informed consent for biopsies. The medical ethical committees of Hospital de la Santa Creu i Sant Pau, Barcelona, Spain and Department of Dermatology, University of Utah, Salt Lake City, UT approved all described studies. The study was conducted according to the Declaration of Helsinki Principles. Primary keratinocytes were cultured on a feeder layer of lethally irradiated (X-ray; 50 Gy) 3T3-J2 cells (a gift from Dr J Garlick, Tufts University) as previously described (Rheinwald and Green, 1975) .
Bioengineered PC skin preparation and grafting
Bioengineered human skin equivalents are based on the use of fibrin, containing live fibroblasts, as the dermal component (Del Rio et al., 2002) . Briefly, 1 ml of fibrinogen (from blood cryoprecipitates) was added to 2 ml of DMEM with 10% fetal calf serum containing 1.5 Â 10 5 dermal fibroblasts and 250 IU of bovine aprotinin (Trasylol; Bayer, West Haven, CT), followed immediately by the addition of 250 ml of 0.025 mM CaCl 2 (Sigma, St Louis, MO) containing 11 IU of human thrombin (Sigma). This mixture was allowed to clot at 37 1C in 35 mm tissue culture well plates. After 24 hours, normal human or PC-derived keratinocytes were seeded and allowed to grow submerged until reaching confluence. Mice were aseptically cleansed and grafted as previously described (Del Rio et al., 2002; Llames et al., 2004) . Mice were anesthetized, with concomitant analgesia, by intraperitoneal administration of ketamine/metodomidine (Pfizer, Madrid, Spain) and grafted. Briefly, full-thickness 12-mm circular wounds were then created on the dorsum of mice to match size of the prepared skin equivalents. Mouse skin that had been removed to generate the wound was devitalized by three repeated cycles of freezing and thawing and used as a biological bandage, and fixed with sutures ( Ethicon, Somerville, NJ) to protect and hold the skin substitute in place during the grafting procedure. The necrotic mouse skin overlying the graft spontaneously sloughed off, generally within 15 days of grafting, and regenerated human skin became visible. Grafting was performed under sterile conditions, using 6-week-old female nu/nu mice. Mice were housed in pathogen-free conditions using individually ventilated cages (25 air changes per hour) and 10 KGy g-irradiated soft wood pellets as bedding.
Tape stripping and minor trauma in PC skin-humanized mice Ordinary paper adhesive tape (Tesa AG, Hamburg, Germany) was applied to the stably engrafted human skin on the backs of nude mice (9-12 weeks post grafting) by repeatedly (70 times) presssticking and pulling off the tape (''tape stripping''). A fresh piece of tape was used after every 10 cycles. Following tape stripping, tissue samples (4 mm biopsy punches; Stiefel Lab, Madrid, Spain) were collected from each mouse at 0, 24, 72, 96, 168, and 360 hours (n ¼ 2 to 3 per group). Minor blister-inducing trauma was achieved by slight friction with a plastic pipette tip on the regenerated skin. Biopsies were collected 15 minutes later after blister induction. Skin samples for immunohistochemistry were harvested and fixed in 3.7% formaldehyde. After fixation, the skin biopsy was embedded in paraffin and 4 mm serial sections were generated. Samples to be used for RNA extraction were harvested and frozen immediately in liquid nitrogen.
Histopathological analysis of engrafted human skin
All samples of human skin were analyzed by standard histological and immunohistochemical techniques. Paraffin sections were processed as described (Escamez et al., 2004) . Briefly, formaldehydefixed sections were subjected to antigen retrieval treatment and stained using specific antibodies. The antibodies used were antikeratin K10 (Lab Vision, Thermo Fisher Scientific, Fremont, CA), human-specific anti-involucrin monoclonal antibody (Clone SY5; Sigma), polyclonal anti-loricrin (clone AF-62; Covance, San Diego, CA), polyclonal anti-K9 (clone D-16; Santa Cruz Biotechnology, Santa Cruz, CA), and polyclonal anti-K5 (AF 138; Covance). The hyperplastic response was assessed through both the analysis of epidermal cell proliferation using a specific Ki67 (Clone SP6, rabbit monoclonal) antibody and the immunodetection of expression of keratins K6 (LHK6B, mouse monoclonal) and K16 (Clone LL025, mouse monoclonal) with specific antibodies (Lab Vision). Immunodetection was performed according to the manufacturer's protocol. Immunoperoxidase staining was developed using the Vectastain ABC kit (Vector Laboratories, Burlingame, CA) and immuno-alkaline phosphatase staining with the UltraVision LP Detection System (Lab Vision). Epidermal thickness was calculated as the distance between the top of the granular layer and the bottom of the basal layer.
Quantitative real-time reverse transcriptase-PCR analysis RNA was isolated from human skin grafts using Trizol reagent (Gibco BRL, Barcelona, Spain) and analyzed by quantitative real-time reverse transcriptase-PCR. RNA isolated from skin samples or tissue culture cells was reverse transcribed using the Superscript III first strand synthesis system (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. Briefly, 1 mg of total RNA (8 ml) was incubated with random hexamer primers (5 ng ml -1 , final concentration) and dNTPs (1 mM, final concentration) at 65 1C for 5 minutes in a final volume of 10 ml and then placed on ice for at least 1 minute.
The reverse transcription reaction was performed using 1 ml Superscript III reverse transcriptase (200 U ml -1 ) in 1 Â buffer (20 mM TrisHCl (pH 8.4), 500 mM KCl, 5 mM MgCl 2 , and 10 mM dithiothreitol) and 1 ml RNase OUT (40 U ml -1 ) at 25 1C for 10 minutes, followed by 50 1C for 50 minutes, according to the manufacturer's instructions. The enzyme was heat denatured at 85 1C for 5 minutes and the RNA template removed by treatment with 1 ml RNase H (2 U ml -1 ) at 37 1C for 20 minutes. Each 25 ml PCR reaction contained 5 ml of 0.2 ng ml -1 complementary DNA, 1.25 ml 20 Â gene expression assay, 6.25 ml H 2 O, and 12.5 ml 2 Â TaqMan master mix. b-Actin, GAPDH (glyceraldehyde-3-phosphate dehydrogenase), K5, K6b, K14, K16, and K17 inventoried TaqMan gene expression assays were obtained from Applied Biosystems (ABI, Foster City, CA). The K6a wild-type and p.Asn171Lys mutant custom assays (capable of complete discrimination between the mutant and wild-type K6a targets) are described in Hickerson et al. (this issue) . Samples were analyzed using the ABI standard 7,500 procedure. The data were analyzed with the Applied Biosystems Sequence Detection software (version 1.4) and reported as the relative quantitation using GAPDH mRNA as the endogenous control. All data points reported are the mean of three replicate assays and error is reported as SE.
